TriangleDISEASE & TREATMENT SETTING
Zynyz: metastatic Merkel cell carcinoma
Source-derived catalogue. This is not a treatment recommendation or a personalised trial match.
Exact scope
Adult patients with metastatic or recurrent locally advanced Merkel cell carcinoma (MCC)
Broader topic: Merkel Cell Carcinoma
- Source population
- Not part of this definition
- Disease extent
- metastatic
- Treatment line
- Not part of this definition
- Stage
- Not part of this definition
- Resectability
- Not part of this definition
Biomarkers, prior therapy and derivation
- molecular
- prior therapy
- derivation status
- source-attested
- derivation note
- Scoped from the FDA approved indication for Zynyz (retifanlimab-dlwr) (accelerated-approval table). Only dimensions stated in that wording are part of this definition.
- source wording
- Adult patients with metastatic or recurrent locally advanced Merkel cell carcinoma (MCC)
Study evidence for this setting
Source relationships and population-mapping limitations
- bindings
- mappings
Download this complete draft source relationship record →
Preserved source evidence · Not medical advice